Latest News

In March and April just 97 cases of prostate cancer were diagnosed throughout Hartford Healthcare compared with 233 cases in 2019. The stark decline holds true for digestive cancers with a 42 percent decline in diagnoses and breast cancer with a 30 percent decline in diagnoses compared to the same period in 2019.

Yale Cancer Center (YCC) scientists have identified mutations in metabolite-producing genes as a disruption of DNA repair.

Matthew Goldenberg, MD, Associate Professor of Psychiatry, and Kirsten Wilkins, MD, Associate Professor of Psychiatry, are co-authors of a paper published in Medical Science Educator that describes the decision by Yale School of Medicine to suspend medical student clerkships as a result of the COVID-19 pandemic.

As physicians, students who aspire to be physicians or physician associates, and staff engaged in patient care, education, and discovery, we hold our responsibility for human life above all else.

International case numbers as of June 1, 2020, 10:00 am.

Professor Harvey Risch, M.D., Ph.D., is a researcher at the Yale School of Public Health with a specialty in cancer etiology, prevention and early diagnosis, and epidemiologic methods. He recently studied the efficacy of hydroxychloroquine (used in conjunction with two other drugs) to treat people infected with COVID-19 and concluded that the approach should be “widely available” in the fight against the current pandemic.

As an assistant professor in the Radiology & Biomedical Imaging Department at Yale School of Medicine, Anne Marie Boustani, MD, interprets diagnostic and molecular imaging for the management of cancer and other diseases. Boustani joined the department five years ago after completing a fellowship in nuclear medicine. But before she attended medical school and trained as a radiologist, she followed a different path, completing a two-year graduate program in medical and biological illustration at Johns Hopkins University. Now, she is using her skills as an MD and an artist to create medical images for her peers.

A team of student and faculty investigators at Yale University has devised a new method for calculating COVID-19 fatality rates in the United States that it says will better guide the country through its reopening, and more accurately drive health care policy decisions regarding the pandemic. Fatality rates have been difficult to calculate in regions without extensive testing due to many infected individuals not being detected.

"When people ask me about my intern year, I have a few seconds to pick my response. Sometimes, I buy a little time by pretending to ponder deeply. But really, I’m just thinking about which version to choose. Should I choose the comfortable answer?"